Guest User 10/17/17 Guest User 10/17/17 Cellular Pioneering: Dr. Jeffrey Conn InnovationBy America'sBiopharmaceuticalCompanies Read More Bruce Melancon 9/12/17 Bruce Melancon 9/12/17 VCNDD partners with VUMC and Bayer to develop new therapies for Kidney disease VUMC Reporter Read More Alex tapper 8/17/17 Alex tapper 8/17/17 Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study Alzheimer's News Today Read More Alex tapper 8/9/17 Alex tapper 8/9/17 VCNDD drug candidate enters clinical trials at Vanderbilt. WSMV Channel 4 - Nashville Read More Alex tapper 8/7/17 Alex tapper 8/7/17 Vanderbilt begins phase 1 trials of new Alzheimer’s drug Research News @ Vanderbilt Read More Newer Posts Older Posts
Guest User 10/17/17 Guest User 10/17/17 Cellular Pioneering: Dr. Jeffrey Conn InnovationBy America'sBiopharmaceuticalCompanies Read More
Bruce Melancon 9/12/17 Bruce Melancon 9/12/17 VCNDD partners with VUMC and Bayer to develop new therapies for Kidney disease VUMC Reporter Read More
Alex tapper 8/17/17 Alex tapper 8/17/17 Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study Alzheimer's News Today Read More
Alex tapper 8/9/17 Alex tapper 8/9/17 VCNDD drug candidate enters clinical trials at Vanderbilt. WSMV Channel 4 - Nashville Read More
Alex tapper 8/7/17 Alex tapper 8/7/17 Vanderbilt begins phase 1 trials of new Alzheimer’s drug Research News @ Vanderbilt Read More
